Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting?

about

Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting?

Item

http://www.wikidata.org/entity/Q35911584

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Will the potential of peroxiso ...... lized in the clinical setting?

@ast

Will the potential of peroxiso ...... lized in the clinical setting?

@en

type

Item

label

Will the potential of peroxiso ...... lized in the clinical setting?

@ast

Will the potential of peroxiso ...... lized in the clinical setting?

@en

prefLabel

Will the potential of peroxiso ...... lized in the clinical setting?

@ast

Will the potential of peroxiso ...... lized in the clinical setting?

@en

P1476

Will the potential of peroxiso ...... lized in the clinical setting?

@en

P2093

Dennis Bruemmer

http://www.w3.org/2001/XMLSchema#string

Florian Blaschke

http://www.w3.org/2001/XMLSchema#string

Ronald E. Law

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of fibrates on lipid and lipoprotein metabolism

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.

Intravascular ultrasound: novel pathophysiological insights and current clinical applications.

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.

Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.

Expression and function of PPARgamma in rat and human vascular smooth muscle cells.

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells.

Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses.

P304

3-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CLC.4960271603

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8244666

http://www.w3.org/2001/XMLSchema#string

P698

15470905

http://www.w3.org/2001/XMLSchema#string

P932

6654069

http://www.w3.org/2001/XMLSchema#string